Does chronic inflammation blunt HPA-axis activity and cause fatigue with higher WBC, platelets, and MPV?

Chronic inflammation acts as a systemic stressor that significantly alters both endocrine function and hematological profiles, often manifesting as persistent fatigue.

Clinical evidence and fatigue

Research consistently demonstrates that chronic inflammatory signaling—specifically elevated Interleukin-6 (IL-6) and C-reactive protein (CRP)—is a primary predictor of fatigue. In older populations, these markers correlate with reduced functional capacity and "sickness behavior" independent of other comorbidities. This state is frequently paired with a blunted HPA axis. While acute stress triggers a protective surge in cortisol, chronic exposure to inflammatory cytokines eventually leads to HPA-axis hyporeactivity. This results in flattened diurnal cortisol rhythms and systemic hypocortisolism, which fails to suppress ongoing inflammatory signaling, thereby perpetuating a cycle of low energy.

Mechanistic explanations

• HPA-axis blunting: Chronic exposure to TNF-α and IL-6 induces glucocorticoid receptor (GR) resistance, characterized by reduced receptor expression and impaired nuclear translocation. Furthermore, inflammation downregulates the ACTH receptor (MC2R) in the adrenal cortex and accumulates succinate, which interferes with steroidogenic pathways, rendering the adrenal glands less responsive to signaling.
• Neurological fatigue: Pro-inflammatory cytokines cross the blood-brain barrier to activate microglia, leading to neuroinflammation. This disrupts neurotransmitter regulation by oxidizing tetrahydrobiopterin (BH4), a critical cofactor for dopamine and serotonin synthesis. Simultaneously, oxidative stress damages neuronal mitochondria, impairing ATP production and creating a cellular energy deficit.
• Hematological shifts: Systemic inflammation triggers the bone marrow to accelerate production of immune cells. Cytokines like IL-1 and IL-6 drive leukocytosis (elevated white blood cells) and reactive thrombocytosis (elevated platelets). Mean Platelet Volume (MPV) typically increases during these states as the marrow releases larger, more metabolically active young platelets to meet inflammatory demand.

Bottom line

Chronic inflammation drives a transition from HPA-axis activation to exhaustion, which, combined with cytokine-induced neuroinflammation and mitochondrial impairment, manifests as persistent fatigue. These physiological shifts are reliably reflected in blood work through elevated white cell counts, increased platelet counts, and higher MPV.